Brigham and Womens Faulkner Hospital is a licensed substance use treatment provider in Jamaica Plain, MA, listed in the SAMHSA treatment directory. It offers hospital inpatient care with medical staff on site around the clock. Outpatient care is offered, so clients can keep living at home between scheduled sessions. On site detox services are available, so withdrawal can be managed before treatment begins. Buprenorphine (Suboxone) is offered to reduce opioid cravings and lower relapse and overdose risk. Naltrexone is used to support recovery from opioid or alcohol use disorder. The program treats co-occurring mental health conditions alongside addiction. The facility reports accepting MassHealth. Private health insurance is accepted. It serves young adults, adults, seniors.
Availability and current services change often. Call (888) 470-5244
and we will help you confirm openings, insurance, and next steps.
Levels of care
Hospital inpatient/24-hour hospital inpatientOutpatientHospital inpatient detoxificationOutpatient detoxificationOutpatient day treatment or partial hospitalizationOutpatient methadone/buprenorphine or naltrexone treatmentRegular outpatient treatment
Type of care
Substance use treatmentDetoxification
Medications
Buprenorphine used in TreatmentNaltrexone used in Treatment
Detox services
Alcohol DetoxificationBenzodiazepines DetoxificationOpioids detoxificationMedication routinely used during detoxification
Payment accepted
MedicareMedicaidFederal military insurance (e.g., TRICARE)Private health insuranceCash or self-paymentState-financed health insurance plan other than Medicaid
Ages served
Young AdultsAdultsSeniors
Accreditation
State substance use treatment agencyState mental health departmentState department of healthHospital licensing authorityThe Joint Commission
Free & confidential, 24/7
Not sure which program fits? Talk it through with someone who can help.
Hospital inpatient/24-hour hospital inpatientHospital inpatient treatmentFederal, or any government funding for substance use treatment programsMedicare
OutpatientOutpatient methadone/buprenorphine or naltrexone treatmentRegular outpatient treatmentFederal, or any government funding for substance use treatment programsMedicare